Abstract:Cell-penetrating peptide (CPP), also called "Trojan Horse" peptide, has become a successful approach to deliver various payloads into cells for achieving the intracellular access. However, the "Trojan Horse" peptide is too wild, not just to "Troy", but rather widely distributed in the body. Thus, there is an urgent need to tame the wildness of "Trojan Horse" peptide for targeted delivery of antineoplastic agents to the tumor site. To achieve this goal, we exploit a masked CPP-doxorubicin conjugate platform for targeted delivery of chemotherapeutic drugs using charge-guided masking and protease-triggered demasking strategies. In this platform, the cell-penetrating function of the positively CPP (d-form nonaarginine) is abrogated by a negatively shielding peptide (masked CPP), and between them is a cleavable substrate peptide by the protease (MMP-2/9). Protease-triggered demasking would occur when the masked CPP reached the MMP-2/9-riched tumor. The CPP-doxorubicin conjugate (CPP-Dox) and the masked CPP-Dox conjugate (mCPP-Dox) were used as models for the evaluation of masking and demasking processes. It was found that exogenous MMP-2/9 could effectively trigger the reversion of CPP-cargo in this conjugate, and this trigger adhered to the Michaelis-Menten kinetics profile. This conjugate was sensitive to the trigger of endogenous MMP-2/9 and could induce enhanced cytotoxicity toward MMP-2/9-rich tumor cells. In vivo antitumor efficacy revealed that this masked conjugate had considerable antitumor activity and could inhibit the tumor growth at a higher level relative to CPP-cargo. Low toxicity in vivo showed the noticeably decreased wildness of this conjugate toward normal tissues and more controllable entry of antitumor agents into "Troy". On the basis of analyses in vitro and in vivo, this mCPP-cargo conjugate delivery system held an improved selectivity toward MMP-2/9-rich tumors and would be a promising strategy for tumor-targeted treatment.

Charge-guided Masking of a Membrane-Destabilizing Peptide Enables Efficient Endosomal Escape for Targeted Intracellular Delivery of Proteins

Engineered Histidine-Rich Peptides Enhance Endosomal Escape for Antibody-Targeted Intracellular Delivery of Functional Proteins

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

E3MPH16: An efficient endosomolytic peptide for intracellular protein delivery

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.

Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers.

Cytosolic Protein Delivery for Intracellular Antigen Targeting Using Supercharged Polypeptide Delivery Platform

Discovery of endosomalytic cell-penetrating peptides based on bacterial membrane-targeting sequences

Inside Cover: Engineered Histidine‐Rich Peptides Enhance Endosomal Escape for Antibody‐Targeted Intracellular Delivery of Functional Proteins (Angew. Chem. Int. Ed. 38/2023)

Enzyme-modulate Conformational Changes in Amphiphile Peptide for Selectively Cell Delivery

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape

Intracellular biomacromolecule delivery by stimuli responsive protein vesicles loaded by hydrophobic ion pairing

A high hydrophobic moment arginine-rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity

Endoprotease-mediated intracellular protein delivery using nanocapsules.

Endocytosis Pathway Self-Regulation for Precise Image-Guided Therapy through an Enzyme-Responsive Modular Peptide Probe

Rational Design of a Polymer with Robust Efficacy for Intracellular Protein and Peptide Delivery

Overcoming Endosomal Escape Barriers in Gene Drug Delivery Using De Novo Designed Ph-Responsive Peptides

Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics

Intracellular delivery strategies using membrane-interacting peptides and proteins

Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides